TickerFacts.

Target Group Inc. (CBDY): Cost of Revenue

Annual figures by period end, from SEC filings.

$1.81M
Year ended 2025-12-31
$2.12M
Trailing 12 months to 2026-06-30
n/m
5-year compound annual growth
$2.87M2019-12-31: $02020-12-31: $25.0K2022-12-31: $02023-12-31: $2.07M2024-12-31: $2.87M2025-12-31: $1.81M$1.81M
2019-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$1.81M-36.7%2026-03-31, From 2025-01-01
2024-12-31$2.87M+38.8%2026-03-31, From 2024-01-01
2023-12-31$2.07Mn/a2025-03-27, From 2023-01-01
2022-12-31$0n/a2024-03-20, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$25.0Kn/a2022-03-18, From 2020-01-01
2019-12-31$0n/a2021-03-30, From 2019-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Target Group Inc. (CBDY)2025-12-31$1.81M-36.7%
Healthy Extracts Inc. (HYEX)2025-12-31$2.09M+73.8%
Functional Brands Inc. (MEHA)2025-12-31$3.13M+5.7%
TFA Therapeutics, Inc. (RAJAF)2025-12-31$484.6K+39.7%
Bon Natural Life Ltd (BON)2025-09-30$14.79M-11.6%
Charlie's Holdings, Inc. (CHUC)2025-12-31$15.26M+212.2%
Adia Nutrition, Inc. (ADIA)2025-12-31$508.8Kn/m
Cyanotech Corp (CYAN)2025-03-31$17.34M+1.2%
Synergy CHC Corp. (SNYRQ)2025-12-31$10.08M-9.9%

Compare CBDY, HYEX, MEHA, RAJAF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗